Oscar R Benavente Selected Research

Oscar R Benavente Research Topics

Disease

54	Stroke (Strokes) 12/2021 - 06/2002
24	Lacunar Stroke 08/2019 - 01/2011
15	Ischemic Stroke 08/2022 - 08/2012
8	Hemorrhage 11/2023 - 08/2012
6	Hypertension (High Blood Pressure) 01/2021 - 01/2017
5	Myocardial Infarction 01/2021 - 08/2012
4	Diabetes Mellitus 01/2021 - 09/2014
4	Infarction (Infarctions) 01/2020 - 09/2014
4	Cognitive Dysfunction 06/2015 - 02/2007
3	Atrial Fibrillation 12/2023 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2019
3	Transient Ischemic Attack 01/2020 - 02/2011
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 08/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2014
2	Cerebral Hemorrhage 01/2019 - 07/2013
2	Vascular Diseases (Vascular Disease) 07/2015 - 08/2012
1	Venous Thromboembolism 11/2023
1	Syncope (Fainting) 12/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 08/2019
1	Cerebral Small Vessel Diseases 01/2019
1	Pathologic Constriction (Stenosis) 06/2018
1	Intracranial Embolism 06/2018
1	Embolic Stroke 06/2018
1	Ischemia 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Disease Progression 07/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015
1	Brain Ischemia (Cerebral Ischemia) 07/2015
1	Pathologic Dilatation (Ectasia) 05/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2014
1	Isolated Systolic Hypertension 10/2014

Drug/Important Bio-Agent (IBA)

15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 02/2011
12	Clopidogrel (Plavix)FDA Link 01/2018 - 02/2011
5	AnticoagulantsIBA 12/2023 - 06/2018
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 02/2011
2	RivaroxabanIBA 11/2023 - 06/2018
2	C-Reactive ProteinIBA 01/2020 - 03/2014
2	Cilostazol (Pletal)FDA LinkGeneric 01/2019 - 04/2015
2	Phosphodiesterase InhibitorsIBA 01/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 03/2016 - 03/2014
2	Dipyridamole (Persantine)FDA LinkGeneric 04/2015 - 02/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023
1	Complement System Proteins (Complement)IBA 08/2022
1	Blood Group Antigens (Blood Groups)IBA 08/2022
1	GenieIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	DiureticsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ThiazidesIBA 01/2021
1	Dabigatran FDA Link 01/2020
1	LipidsIBA 01/2020
1	hydroxide ionIBA 08/2019
1	CholesterolIBA 01/2019
1	Verapamil (Calan)FDA LinkGeneric 01/2019
1	trandolapril (Mavik)FDA LinkGeneric 01/2019
1	Factor Xa InhibitorsIBA 06/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	Cocaine (Cocaine HCl)IBA 04/2016
1	Illicit Drugs (Recreational Drugs)IBA 04/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2016
1	CD40 Ligand (CD40L)IBA 03/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2016
1	Cytochrome P-450 CYP2C19IBA 05/2015
1	Hemoglobins (Hemoglobin)IBA 10/2014

Therapy/Procedure

38	Secondary Prevention 12/2021 - 02/2007
14	Therapeutics 01/2019 - 01/2011
1	Percutaneous Coronary Intervention 05/2015
1	Activities of Daily Living (ADL) 03/2015
1	DDP-BLM protocol 08/2014
1	Thrombolytic Therapy 07/2013
1	Endarterectomy (Thromboendarterectomy) 06/2002